CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...